Corporate Intranet Refresh Request report walkthrough

Positive signals

• The business case is detailed enough to support a serious approval discussion.
• Commercial context is clear enough to anchor the fit discussion.

Risks to close

• Outcome definition risk: the desired outcome exists but is still broad enough to invite competing interpretations.
• Approval gate risk: no sponsor is named to confirm the project is worth funding and prioritizing.
• Budget boundary risk: no investment guardrails are captured yet, so value cannot be weighed against expected spend.
• Measurement risk: no success metrics are documented, so the business case is hard to validate after approval.

Evidence from intake

• The business justification is substantial and describes why this work matters now.
• Client, sector, or project-type context is documented in the intake.

Recommendations

• Rewrite the desired outcome as a concise business result with a clear before-and-after state.
• Assign a sponsor who can approve scope tradeoffs and confirm the project remains worth doing.
• Capture a budget range or funding guardrail so reviewers can judge value against spend.
• Add measurable outcomes that define how this project will prove it created business value.

Positive signals

No positive signals are currently captured.

Risks to close

• Scope narrative risk: the scope summary is too light to anchor a dependable baseline.
• Requirement completeness risk: the project does not yet have a reviewable requirement set.
• Priority boundary risk: the intake does not yet separate critical scope from optional asks clearly enough.
• Boundary definition risk: there is no explicit out-of-scope list yet, which leaves room for uncontrolled expansion.

Evidence from intake

No direct intake evidence is currently available.

Recommendations

• Rewrite the scope summary into a clearer baseline narrative before approval.
• Document the core requirements that define what must actually be delivered.
• Confirm which outcomes are true must-haves versus lower-priority scope so approvals can focus on the real baseline.
• Add explicit out-of-scope statements before approval so the phase boundary is defendable.

Positive signals

No positive signals are currently captured.

Risks to close

• Ownership risk: no sponsor is assigned to arbitrate readiness tradeoffs and approval decisions.
• Stakeholder coverage risk: stakeholder mapping has started, but it may still miss a critical reviewer or approver.
• Delivery ownership risk: no team roles are documented, so staffing feasibility is still speculative.
• Owner assignment risk: roles are listed, but none have named owners yet.

Evidence from intake

No direct intake evidence is currently available.

Recommendations

• Assign a sponsor who can resolve tradeoffs and close readiness decisions promptly.
• Confirm the full review and approval stakeholder set so no essential voice is missing later.
• Define the core delivery roles required for the work before approval proceeds.
• Assign named owners to the critical delivery roles so resource readiness is reviewable.

Positive signals

• The current scope volume does not obviously overwhelm the schedule at first pass.

Risks to close

• Schedule definition risk: target start and launch dates are not both defined yet.
• Dependency ambiguity risk: the intake does not yet explain why the proposed timeline should be believable.
• Constraint visibility risk: the schedule is harder to trust because the intake does not document the limiting constraints.
• Capacity planning risk: the timeline is difficult to trust without enough role coverage to map work against.

Evidence from intake

No direct intake evidence is currently available.

Recommendations

• Set both a target start and target launch date so timeline confidence can be reviewed on something concrete.
• Document milestones, dependencies, procurement lead times, and approval gates that shape the proposed schedule.
• Capture the constraints that could compress, delay, or stage the timeline.
• Define the key delivery roles before committing to the current timeline.

Positive signals

• The business rationale is detailed enough to support a value discussion.

Risks to close

• Outcome measurement risk: an outcome is present, but it is still too broad to translate cleanly into realized value.
• Measurement coverage risk: no success metrics are documented, so ROI remains largely speculative.
• Budget boundary risk: ROI confidence is weak because there is no investment range or spending context to compare against expected return.
• Value validation risk: no sponsor is assigned to confirm whether the projected return is worth the investment.

Evidence from intake

• Business justification provides a meaningful rationale for expected value.

Recommendations

• Refine the desired outcome into a measurable business result tied to timing or impact.
• Add measurable outcomes that define how value will be tracked after delivery.
• Capture a budget range or cost estimate so reviewers can compare expected return against expected investment.
• Assign a sponsor who can validate the expected return and approve the value case.